New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty
Retrieved on:
Thursday, July 29, 2021
The results of the study, A Multimodal Pain Management Protocol Including Preoperative Cryoneurolysis for Total Knee Arthroplasty to Reduce Pain, Opioid Consumption, and Length of Stay, were published in Arthroplasty Today .
Key Points:
- The results of the study, A Multimodal Pain Management Protocol Including Preoperative Cryoneurolysis for Total Knee Arthroplasty to Reduce Pain, Opioid Consumption, and Length of Stay, were published in Arthroplasty Today .
- This retrospective analysis utilized data from patients who underwent TKA by a single surgeon at one center.
- Patients who received iovera before TKA were compared with a historical control group including patients who underwent TKA without iovera.
- The primary outcome was opioid intake at various time points from hospital stay to 6 weeks after discharge.